Johnson & Johnson

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech.

CEO

Joaquin Duato

CEOJoaquin Duato

Employees

152,700

Employees152,700

Headquarters

New Brunswick, New Jersey

HeadquartersNew Brunswick, New Jersey

Founded

1887

Founded1887

Employees

152,700

Employees152,700

JNJ Key Statistics

Market cap

389.30B

Market cap389.30B

Price-Earnings ratio

33.00

Price-Earnings ratio33.00

Dividend yield

2.81%

Dividend yield2.81%

Average volume

6.76M

Average volume6.76M

High today

$163.49

High today$163.49

Low today

$161.59

Low today$161.59

Open price

$162.61

Open price$162.61

Volume

4.52M

Volume4.52M

52 Week high

$181.04

52 Week high$181.04

52 Week low

$150.11

52 Week low$150.11

JNJ News

Benzinga 12h

Zika Virus Market to Witness Growth by 2032, Estimates DelveInsight | Johnson and Johnson, Aurobindo Phar - Benzinga

"Zika Virus Market" (Albany, USA) DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understandi...

Benzinga 22h

Cutaneous Mastocytosis Treatment Market | Bausch Health Companies Inc., Bayer AG, Johnson & Johnson, Mall - Benzinga

The global cutaneous mastocytosis treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of...

Yahoo Finance 3d

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results - Yahoo Finance

NEW BRUNSWICK, N.J., September 18, 2023--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on...

Analyst ratings

63%

of 24 ratings

Buy

33.3%

Hold

62.5%

Sell

4.2%

JNJ Earnings

$0.00

$0.93

$1.87

$2.80

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Q1 FY23

Q2 FY23

Q3 FY23

Estimated

$2.51 per share

Estimated$2.51 per share

Actual

Available Oct 17, Pre-Market

ActualAvailable Oct 17, Pre-Market

More JNJ News

Fortune 7d

This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business

Good morning, Broadsheet readers! Former Alibaba Group adviser Wei Zhang will join the Starbucks board, Iranian women are still fighting for their rights, and a...